JBJennifer L. Becker

Jennifer L. Becker

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jennifer L. Becker has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    REV-ERBα/β Disruption Drives Environmental Tobacco Smoke-Induced Cellular Senescence Associated with cGAS-STING Signaling Promoting Lung Remodeling

    by Sadiya Bi Shaikh, Md. Imam Faizan, Khursheed Ul Islam, Karen Lin, Qixin Wang, Jennifer Becker, Md. Sohanur Rahman, Kingshuk Panda, Srinivasan Chinnapaiyan, Dongmei Li, et al.

    Cellular senescence and DNA damage are recognized contributors to smoke-induced lung injury. However, how these processes integrate with circadian regulation and innate immune sensing in response to environmental stressors remains incompletely understood. Here, we identify a conserved multi-lineage transcriptional program in murine lungs that we define as the SCPS axis, characterized by Suppressed Clock, Primed Senescence (SCPS), fibrinolytic Shutdown, and cGAS–STING activation. We show that environmental cigarette/tobacco smoke (ETS) exposure induces senescence and SASP factor production in both epithelial and fibroblast populations, even in the presence of an intact molecular clock. Spatial transcriptomic analysis of smoker lungs demonstrates parallel alterations marked by increased expression of senescence-associated genes, activation of DNA damage and innate immune sensors, and repression of core clock genes, particularly within AT2 cells and fibroblasts. Similarly, REVα/β-deficient mice reveal altered lung circadian, cGAS–STING, senescence, and transcriptional programs. Pharmacological clearance of senescent cells effectively reverses these molecular and cellular phenotypes. Together, these findings reveal early epithelial remodeling and fibrotic priming during environmental tobacco smoke exposure and establish a mechanistic link between senescence, circadian disruption, and innate immune activation associated with the cGAS-STING pathway as the SCPS axis for early checkpoint of fibrotic susceptibility.

  • Open Access

    Microglial interferon signaling and Aβ plaque pathology are enhanced in female 5xFAD Alzheimer’s disease mice, independent of estrous cycle stage

    by L. Calcines-Rodríguez, N. Noyes-Martel, J. L. Becker, S. K. Nguyen, M. A. Osabutey, L. A. Trojanczyk, A. K. Majewska, M. K. O’bAnion

    Alzheimer’s disease (AD) presents with a sex bias in which women are at higher risk and exhibit more rapid cognitive decline and brain atrophy compar


  • Open Access

    Sex, not estrous cycle stage, drives differences in the microglial transcriptome in the 5xFAD mouse model of amyloidosis

    by Lia Calcines Rodriguez, Nikita Noyes-Martel, Jennifer L Becker, Ania K Majewska, M.K. O’BAnion, Kerry M O'Banion

    Alzheimer’s disease (AD) presents with a sex bias where women are at higher risk and exhibit worse cognitive decline and brain atrophy compared to men. Microglia play a significant role in the pathogenesis and progression of AD and have been shown to be sexually differentiated in health and disease. Whether microglia contribute to the sex differences in AD remains to be elucidated. Herein, we characterize the sex differences in amyloid-beta (Aβ) plaque pathology and microglia-plaque interaction using the 5xFAD mouse model of amyloidosis and further elucidate the microglial transcriptomic changes that occur in males and females. In females we concentrate on two hormonally distinct stages of the rodent estrous cycle: proestrus and diestrus. Our results indicate that Aβ plaque morphology is sexually distinct with females having greater plaque volume and lower plaque sphericity compared to males. Microglia also interact with plaques in a sexually distinct manner with females phagocytosing Aβ to a greater extent compared to males. Furthermore, we found that female microglia are not overtly different at the proestrus or diestrus stages. However, we found stark sex differences between female and male microglia transcriptomes in the 5xFAD brains, where female 5xFAD microglia were enriched in genes involved in glycolytic metabolism, antigen presentation, disease-associated microglia and microglia neurodegenerative phenotype (DAM/MGnD), and interferon signaling compared to male 5xFAD microglia.


  • Open Access

    Elevated Lactate in the AML Bone Marrow Microenvironment Polarizes Leukemia-Associated Macrophages via GPR81 Signaling

    by Celia A. Soto, Maggie L. Lesch, Jennifer L. Becker, Azmeer Sharipol, Amal Khan, Xenia L. Schafer, Michael W. Becker, Joshua C. Munger, Benjamin J. Frisch

    Interactions between acute myeloid leukemia (AML) and the hematopoietic bone marrow microenvironment (BMME) are critical to leukemia progression and chemoresistance. We measured elevated extracellular metabolites in the BMME of AML patients, including lactate. Lactate has been implicated in solid tumors for inducing suppressive tumor-associated macrophages, and correlates with poor prognosis. We describe a role of lactate in the polarization of leukemia-associated macrophages (LAMs), using a murine model of blast crisis chronic myelogenous leukemia (bcCML). Elevated lactate also diminished the function of hematopoietic progenitors and stromal support in vitro. Mice genetically lacking the lactate receptor GPR81 were used to demonstrate lactate-GPR81 signaling as a mechanism of both the polarization of LAMs and the direct support of leukemia cells. We report microenvironmental lactate as a critical driver of AML-induced BMME dysfunction and leukemic progression, thus identifying GPR81 as an exciting and novel therapeutic target for the treatment of this devastating disease. Significance This research detects elevated metabolites in AML bone marrow and identifies GPR81-lactate signaling as a mechanism of leukemia progression. This preclinical data supports novel therapeutic strategies in the treatment of AML.


  • Open Access

    Increased Osteoclast and Decreased Osteoblast Activity Causes Reduced Bone Mineral Density and Quality in Genetic Hypercalciuric Stone‐Forming Rats

    by Nancy S. Krieger, Luojing Chen, Jennifer Becker, Sean DeBoyace, Hongwei Wang, Murray J. Favus, David A Bushinsky

    To study human idiopathic hypercalciuria (IH), we developed an animal model, genetic hypercalciuric stone‐forming (GHS) rats, whose pathophysiology parallels that in IH. All GHS rats form kidney stones and have decreased BMD and bone quality compared with the founder Sprague–Dawley (SD) rats. To understand the bone defect, we characterized osteoclast and osteoblast activity in the GHS compared with SD rats. Bone marrow cells were isolated from femurs of GHS and SD rats and cultured to optimize differentiation into osteoclasts or osteoblasts. Osteoclasts were stained for TRAcP (tartrate resistant acid phosphatase), cultured to assess resorptive activity, and analyzed for specific gene expression. Marrow stromal cells or primary neonatal calvarial cells were differentiated to osteoblasts, and osteoblastic gene expression as well as mineralization was analyzed. There was increased osteoclastogenesis and increased resorption pit formation in GHS compared with SD cultures. Osteoclasts had increased expression of cathepsin K, Tracp, and MMP9 in cells from GHS compared with SD rats. Osteoblastic gene expression and mineralization was significantly decreased. Thus, alterations in baseline activity of both osteoclasts and osteoblasts in GHS rats, led to decreased BMD and bone quality, perhaps because of their known increase in vitamin D receptors. Better understanding of the role of GHS bone cells in decreased BMD and quality may provide new strategies to mitigate the low BMD and increased fracture risk found in patients with IH. © 2020 The Authors. JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research.